Ubiquitin C-terminal hydrolase-L3 promotes interferon antiviral activity by stabilizing type I-interferon receptor

作者：Zhao, Peng; Guo, Tingting; Qian, Liping; Wang, Xiaofang; Yuan, Yukang; Cheng, Qiao; Zuo, Yibo; Liu, Jin; Miao, Ying; Feng, Qian; Zhang, Liting; Wu, Shuhua^*; Zheng, Hui^*

来源：Antiviral Research, 2017, 144: 120-129.

DOI：10.1016/j.antiviral.2017.06.002

• UCHL3
• Deubiquitination
• SCF beta-TrCP
• Interferon
• Antiviral response

Type-I interferons (IFN-I) are important antiviral drugs which are widely used in clinical therapy of diverse viral infections. However, understanding the detailed mechanisms for IFN-I antiviral signaling remains a major challenge, and may provide novel targets for IFN-based antiviral therapy. So far, the roles of deubiquitinases (DUBs) in regulating IFN-I antiviral activity are still largely unexplored. Here, we find that Ubiquitin C-terminal hydrolase-L3 (UCHL3) plays an important role in regulating type I-interferon (IFN-I) mediated antiviral response. Interestingly, we find that UCHL3 regulates COPS5-dependent deneddylation of Cullin1, which is an essential component of SCF beta-TrCP complex and associated with SCF beta-TrcP activities. Furthermore, we reveal that UCHL3 physically interacts with COPS5, and determines the level and protein stability of cellular COPS5 by deubiquitinating COPS5. We further demonstrate that UCHL3 upregulates the levels of SCF beta-TrCP substrates including IFN-I receptor IFNAR1, which enhances IFN-I mediated signaling pathway and antiviral activity. These findings identify COPS5 as a novel in vivo substrate of UCHL3, and uncover the deubiquitination-deneddylation mediated regulation for IFN-I signaling and antiviral function, which may provide a novel strategy for improving IFN-based antiviral therapy.

• 出版日期2017-8
• 单位苏州大学